{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:10:55Z","timestamp":1768828255357,"version":"3.49.0"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,30]],"date-time":"2012-04-30T00:00:00Z","timestamp":1335744000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0036001","type":"journal-article","created":{"date-parts":[[2012,4,30]],"date-time":"2012-04-30T20:56:29Z","timestamp":1335819389000},"page":"e36001","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["The Cost-Effectiveness of Tuberculosis Preventive Therapy for HIV-Infected Individuals in Southern India: A Trial-Based Analysis"],"prefix":"10.1371","volume":"7","author":[{"given":"Mai T.","family":"Pho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumya","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagalingeswaran","family":"Kumarasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Losina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ponnuraja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren M.","family":"Uhler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Callie A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth H.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth A.","family":"Freedberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rochelle P.","family":"Walensky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,4,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMp078049","article-title":"Tuberculosis and HIV in India.","volume":"356","author":"R Steinbrook","year":"2007","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12038-008-0071-2","article-title":"HIV and tuberculosis in India.","volume":"33","author":"S Swaminathan","year":"2008","journal-title":"J Biosci"},{"key":"ref3","first-page":"839","article-title":"Risk of development of tuberculosis in HIV-infected patients.","volume":"4","author":"S Swaminathan","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref4","article-title":"Global tuberculosis control: surveillance, planning, financing Geneva: World Health Organization","author":"WHO","year":"2008"},{"key":"ref5","first-page":"168","article-title":"Tuberculin skin test results in HIV-infected patients in India: implications for latent tuberculosis treatment.","volume":"12","author":"S Swaminathan","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref6","article-title":"Three I\u2019s meeting: intensified case finding (ICF), isoniazid preventive therapy (IPT) and TB infection control (IC) for people living with HIV.","author":"WHO","year":"2009"},{"key":"ref7","article-title":"RNTCP Status Report.","author":"India TB","year":"2011"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1097\/01.aids.0000279714.60935.a2","article-title":"Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy.","volume":"21","author":"KA Freedberg","year":"2007","journal-title":"AIDS"},{"key":"ref9","article-title":"Efficacy of a 6-month vs.","author":"S Swaminathan","year":"2010"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e12747","DOI":"10.1371\/journal.pone.0012747","article-title":"Cost-Effectiveness of HIV Testing Referral Strategies among Tuberculosis Patients in India.","volume":"5","author":"LM Uhler","year":"2010","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1086\/522546","article-title":"Cost-effectiveness of HIV testing and treatment in the United States.","volume":"45","author":"RP Walensky","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref12","article-title":"Cost-effectiveness in health and medicine.","author":"RM Gold","year":"1996"},{"key":"ref13","article-title":"International Monetary Fund","year":"2009"},{"key":"ref14","article-title":"Macroeconomics and health: Investing in health for economic development.","author":"WHO","year":"2001"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1056\/NEJM200103153441108","article-title":"The cost effectiveness of combination antiretroviral therapy for HIV disease.","volume":"344","author":"KA Freedberg","year":"2001","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.","volume":"126","author":"JW Mellors","year":"1997","journal-title":"Ann Intern Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1473-3099(10)70078-5","article-title":"Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources.","volume":"10","author":"SD Lawn","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"ref18","article-title":"Guidelines for prevention and management of common opportunistic infections\/malignancies among HIV-infected adult and adolescent.","author":"NACO","year":"2007"},{"key":"ref19","article-title":"Antiretroviral therapy: practice guidelines and National ART Programme.","author":"D Bachani","year":"2009"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"Martinson NA, Barnes GL, Moulton LH, Msandiwa R, Hausler H, et al. New regimens to prevent tuberculosis in adults with HIV infection.","volume":"365","journal-title":"N Engl J Med"},{"key":"ref21","author":"T Samandari","year":"1588"},{"key":"ref22","article-title":"Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings.","author":"WHO","year":"2011"},{"key":"ref23","first-page":"896","article-title":"Anti-tuberculosis drug resistance in patients with HIV and tuberculosis in South India.","volume":"9","author":"S Swaminathan","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1086\/497267","article-title":"The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India.","volume":"41","author":"N Kumarasamy","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref25","article-title":"Incidence of opportunistic infections (OIs) within specific CD4 strata in HIV-infected patients in southern India.","author":"B Wang","year":"2006"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/135965350701200416","article-title":"The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Cote d\u2019Ivoire.","volume":"12","author":"E Losina","year":"2007","journal-title":"Antivir Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2471\/BLT.06.032292","article-title":"Progression to WHO criteria for antiretroviral therapy in a 7-year cohort of adult HIV-1 seroconverters in Abidjan, Cote d\u2019Ivoire.","volume":"85","author":"A Minga","year":"2007","journal-title":"Bull World Health Organ"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1089\/aid.2006.0308","article-title":"Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysis.","volume":"23","author":"C Seyler","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.","volume":"359","author":"M Badri","year":"2002","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1001\/jama.283.19.2537","article-title":"Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.","volume":"283","author":"MA Espinal","year":"2000","journal-title":"JAMA"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/QAI.0b013e318042e1c3","article-title":"Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration.","volume":"45","author":"SH Tuboi","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/01.qai.0000145351.96815.d5","article-title":"The TREAT Asia HIV Observational Database: baseline and retrospective data.","volume":"38","author":"J Zhou","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref33","article-title":"YRG Pharmacy.","year":"2009"},{"key":"ref34","volume":"30","author":"Specialties Monthly Index of Medical","year":"2010"},{"key":"ref35","first-page":"12","article-title":"Estimating provider cost for treating patients with tuberculosis under Revised National Tuberculosis Control Programme (RNTCP).","volume":"53","author":"M Muniyandi","year":"2006","journal-title":"Indian Journal of Tuberculosis"},{"key":"ref36","article-title":"Care, Support & Treatment: National AIDS Control Programme, Phase-III, India.","author":"NACO","year":"2010"},{"key":"ref37","article-title":"Economic Analysis of YRG CARE Services,.","author":"GA Homan RK","year":"2000"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000171.pub3","article-title":"Treatment of latent tuberculosis infection in HIV infected persons.","author":"C Akolo","year":"2010"},{"key":"ref39","article-title":"Antiretroviral therapy for HIV infection in adults and adolescents.","author":"WHO","year":"2010"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2471\/BLT.04.018606","article-title":"Costs of measures to control tuberculosis\/HIV in public primary care facilities in Cape Town, South Africa.","volume":"84","author":"HP Hausler","year":"2006","journal-title":"Bull World Health Organ"},{"key":"ref41","first-page":"1281","article-title":"Costs incurred by patients with pulmonary tuberculosis in rural India.","volume":"13","author":"KR John","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref42","first-page":"747","article-title":"Cost-utility of tuberculosis prevention among HIV-infected adults in Kampala, Uganda.","volume":"11","author":"RK Shrestha","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref43","first-page":"713","article-title":"The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia.","volume":"13","author":"BS Sutton","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection.","volume":"365","author":"TR Sterling","journal-title":"N Engl J Med"},{"key":"ref45","first-page":"257","article-title":"Recent developments in treatment of latent tuberculosis infection.","volume":"133","author":"D Menzies","year":"2011","journal-title":"Indian J Med Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-149-10-200811180-00003","article-title":"Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial.","volume":"149","author":"D Menzies","year":"2008","journal-title":"Ann Intern Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/00002030-199908200-00016","article-title":"Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective.","volume":"13","author":"JC Bell","year":"1999","journal-title":"AIDS"},{"key":"ref48","first-page":"75","article-title":"Isoniazid prophylactic therapy for tuberculosis in HIV-seropositive patients\u2013a least-cost analysis.","volume":"85","author":"P Masobe","year":"1995","journal-title":"S Afr Med J"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1086\/651497","article-title":"Integration of tuberculosis and HIV services in sub-Saharan Africa: lessons learned.","volume":"50","author":"AA Howard","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1164\/rccm.200911-1783OC","article-title":"Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana.","volume":"182","author":"Z Tedla","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0277-9536(02)00176-4","article-title":"Predictors of adherence to treatment for latent tuberculosis infection in high-risk Latino adolescents: a behavioral epidemiological analysis.","volume":"56","author":"M Hovell","year":"2003","journal-title":"Soc Sci Med"},{"key":"ref52","first-page":"719","article-title":"Risk factors for failure to complete a course of latent tuberculosis infection treatment in Salvador, Brazil.","volume":"13","author":"A Machado Jr","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/QAD.0b013e328327964f","article-title":"Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.","volume":"23","author":"JE Golub","year":"2009","journal-title":"AIDS"},{"key":"ref54","article-title":"Multidrug and extensively drug-resistant TB: Global report on surveillance and response.","author":"WHO","year":"2010"},{"key":"ref55","first-page":"14","article-title":"Usefulness of an observational database to assess antiretroviral treatment trends in India.","volume":"19","author":"AJ Cecelia","year":"2006","journal-title":"Natl Med J India"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/0019-5359.53163","article-title":"Survival analysis and risk factors for death in tuberculosis patients on directly observed treatment-short course.","volume":"63","author":"G Pardeshi","year":"2009","journal-title":"Indian J Med Sci"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1592\/phco.29.5.503","article-title":"Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection.","volume":"29","author":"DP Holland","year":"2009","journal-title":"Pharmacotherapy"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0036001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T01:51:56Z","timestamp":1713923516000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0036001"}},"subtitle":[],"editor":[{"given":"Madhukar","family":"Pai","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,30]]},"references-count":57,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0036001","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,30]]}}}